Heart Fail Clin. 2026 Apr;22(2):149-162. doi: 10.1016/j.hfc.2025.11.003. Epub 2025 Dec 22.
ABSTRACT
Ventricular arrhythmia remains a challenge in the heart failure population, resulting in significant morbidity and mortality despite modern heart failure therapies. Patients with heart failure who have ventricular arrhythmia experience morbidity related to electrical storm, cardiogenic shock, and device therapies and are at an increased risk for sudden cardiac arrest and death. The management of ventricular arrhythmia involves antiarrhythmic drugs, cardiac implantable electronic device, catheter ablation, and other adjunctive procedural management strategies. Early intervention can reduce recurrent ventricular arrhythmia, device therapies, and associated morbidity and mortality and is essential in the management of ventricular arrhythmia in the patient with heart failure.
PMID:41895893 | DOI:10.1016/j.hfc.2025.11.003